Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bilateral Blindness Due to Radiation-Induced Optic Neuropathy in a Patient with Nasal Mucosal Melanoma.

Created on 10 Aug 2026

Authors

Mauricio Agustin Benetti, Luciana León-Cejas, Luis Ariel Miquelini, Dolores Ribero-Ayerza, Francisco Caiza-Zambrano, Ricardo Reisin

Published in

Romanian journal of ophthalmology. Volume 70. Issue 2. Pages 338-342.

Abstract

Radiation-induced optic neuropathy is an uncommon but devastating complication of radiotherapy for head and neck tumors, characterized by subacute, painless, irreversible visual loss. Nasal mucosal melanoma, although rare, carries a high risk of visual pathway toxicity due to its proximity to anterior optic structures. We report the case of a 73-year-old woman with right nasal mucosal melanoma treated with adjuvant radiotherapy (66 Gy) and anti-PD1 immunotherapy, who developed progressive bilateral vision loss. Neuro-ophthalmological examination revealed severe visual acuity reduction, bilateral mydriasis, and optic disc pallor. Optical coherence tomography showed retinal nerve fiber layer thinning. Brain MRI demonstrated contrast enhancement of the optic chiasm and prechiasmatic optic nerves. Despite intensive treatment, the patient progressed to bilateral blindness. This case underscores the importance of early recognition of radiation-induced optic neuropathy, particularly in high-risk anatomical sites and in patients receiving radiotherapy combined with immunotherapy.

PMID:
42572628
Bibliographic data and abstract were imported from PubMed on 10 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement